Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2818-07-7 | MDL No. : | MFCD02179576 |
Formula : | C8H9NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QQPMGRCCMQUJJA-UHFFFAOYSA-N |
M.W : | 183.16 | Pubchem ID : | 12317089 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.35 |
TPSA : | 68.39 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.88 cm/s |
Log Po/w (iLOGP) : | 1.94 |
Log Po/w (XLOGP3) : | 0.75 |
Log Po/w (WLOGP) : | 0.59 |
Log Po/w (MLOGP) : | 0.02 |
Log Po/w (SILICOS-IT) : | 1.15 |
Consensus Log Po/w : | 0.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.47 |
Solubility : | 6.22 mg/ml ; 0.034 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.77 |
Solubility : | 3.14 mg/ml ; 0.0172 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.76 |
Solubility : | 3.18 mg/ml ; 0.0173 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.96 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
48% | With copper(I) oxide; 1,10-Phenanthroline In 1,4-dioxane at 100℃; for 2 h; | Step A: To a solution of cuprous oxide (832 mg, 5.9 mmol) and 1,10- phenanthroline (2.14 g, 11.89 mmol) in dioxane (200 mL) were added methyl propiolate (10 g, 118.9 mmol) and methyl isocyanoacetate (8.95 g, 98.6 mmol). The reaction mixture was heated at 100 0C for 2 h. The mixture was filtered through Celite, solvents were evaporated, and the residue was purified by silica gel chromatography using a mixture of EtOAc-hexanes as eluent. The isolated product was sonicated with DCM to afford dimethyl lH-pyrrole-2,4-dicarboxylate (8.6 gm, 48 percent).) as a solid. 1H NMR : (300 MHz, DMSCwZ6) δ 12.55 (s, IH), 7.60 (s, IH), 7.10 (s, IH), 3.92 (s, 3H)5 3.90 (s, 3H); LC-MS (ESI) m/z 184 (M+H)+. |
[ 7126-57-0 ]
Ethyl 4-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.90
[ 2436-79-5 ]
Diethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate
Similarity: 0.89
[ 67858-47-3 ]
Methyl 4-formyl-1-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.89
[ 36131-43-8 ]
Ethyl 3-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.87
[ 107516-75-6 ]
Diethyl 1H-indole-2,6-dicarboxylate
Similarity: 0.86
[ 7126-57-0 ]
Ethyl 4-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.90
[ 2436-79-5 ]
Diethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate
Similarity: 0.89
[ 67858-47-3 ]
Methyl 4-formyl-1-methyl-1H-pyrrole-2-carboxylate
Similarity: 0.89
[ 1125-32-2 ]
1H-Pyrrole-2,3-dicarboxylic acid
Similarity: 0.88
[ 36131-43-8 ]
Ethyl 3-formyl-1H-pyrrole-2-carboxylate
Similarity: 0.87